given
continu
exposur
outsid
environ
respiratori
mucosa
highli
suscept
viral
infect
human
respiratori
tract
infect
varieti
pulmonari
virus
includ
respiratori
syncyti
viru
rsv
influenza
viru
human
metapneumoviru
hmpv
rhinoviru
rv
coronaviru
cov
parainfluenza
viru
piv
sever
diseas
associ
respiratori
viral
infect
vari
wide
depend
viru
strain
well
age
immun
statu
infect
individu
symptom
rang
mild
sinus
coldlik
symptom
sever
symptom
includ
bronchiti
pneumonia
even
death
rsv
lead
caus
sever
lower
respiratori
tract
infect
children
year
age
rsv
commonli
associ
sever
lower
respiratori
tract
symptom
includ
bronchiol
pneumonia
bronchiti
signific
caus
hospit
mortal
children
elderli
immunocompromis
individu
similarli
piv
commonli
infect
children
major
caus
croup
pneumonia
bronchiol
season
influenza
infect
often
influenza
viru
iav
subtyp
respons
million
case
sever
infect
annual
season
iav
infect
also
result
approxim
death
per
year
commonli
either
young
children
elderli
popul
howev
infect
emerg
pandem
iav
strain
pandem
strain
primarili
induc
sever
diseas
mortal
otherwis
healthi
adult
younger
year
age
contrast
respiratori
infect
hmpv
rv
cov
commonli
associ
symptom
common
cold
two
notabl
except
sever
acut
respiratori
syndrom
sar
cov
middl
east
respiratori
syndrom
mer
cov
caus
acut
respiratori
distress
mortal
infect
individu
despit
profound
impact
human
health
common
respiratori
virus
lack
approv
vaccin
strategi
employ
often
vaccin
develop
induct
robust
neutral
antibodi
respons
howev
hallmark
mani
respiratori
viral
infect
includ
rsv
hmpv
rv
abil
reinfect
occur
frequent
throughout
life
suggest
antibodi
respons
respiratori
virus
may
wane
time
inde
despit
correl
preexist
nasal
iga
protect
reinfect
develop
longlast
rsv
rvspecif
mucos
iga
respons
poor
infect
adult
although
iavspecif
neutral
antibodi
elicit
effici
either
infect
vaccin
iav
vaccin
formul
must
redevelop
annual
account
rapid
mutat
ha
na
gene
season
strain
therefor
vaccin
sole
promot
induct
neutral
antibodi
may
optim
provid
protect
mani
respiratori
viru
infect
induct
cellular
immun
respons
thu
far
receiv
littl
attent
respiratori
viru
vaccin
develop
cell
play
critic
role
mediat
viral
clearanc
follow
mani
respiratori
viru
infect
includ
rsv
iav
hmpv
addit
recent
murin
studi
util
cell
epitopespecif
immun
strategi
observ
significantli
reduc
lung
viral
titer
follow
iav
rsv
sar
challeng
therefor
induct
virusspecif
cell
respons
potenti
improv
upon
efficaci
current
vaccin
strategi
review
current
literatur
cell
respons
follow
respiratori
viru
infect
discuss
knowledg
may
best
util
develop
futur
vaccin
follow
acut
respiratori
infect
dendrit
cell
dc
taken
viral
antigen
stimul
activ
naiv
cell
lung
drain
lymph
node
induc
robust
virusspecif
cell
respons
review
ref
respiratori
viru
infect
mous
model
result
increas
frequenc
number
total
antigenspecif
cell
lung
airway
rsvspecif
cell
respons
typic
reach
peak
number
lung
approxim
day
follow
acut
infect
kinet
virusspecif
cell
slightli
delay
follow
respiratori
viru
infect
peak
occur
approxim
day
iav
day
hmpv
day
pneumonia
viru
mice
pvm
model
respiratori
viru
peak
antigenspecif
cell
respons
gener
correspond
lung
viral
clearanc
follow
rsv
iav
hmpv
pvm
infect
human
cell
kinet
follow
respiratori
viru
infect
less
well
known
given
lack
identifi
cell
epitop
difficulti
obtain
respiratori
tract
sampl
children
follow
initi
viru
exposur
frequenc
total
activ
cell
tracheal
aspir
peak
approxim
day
onset
symptom
children
rsv
iav
rv
cov
infect
rsvspecif
cell
detect
tracheal
aspir
children
howev
evalu
epitop
present
low
frequenc
compris
total
cell
respons
follow
peak
expans
cell
contract
occur
memori
popul
virusspecif
cell
remain
within
lung
major
virusspecif
cell
locat
within
lung
parenchyma
rather
pulmonari
vasculatur
follow
local
respiratori
infect
mice
similarli
human
rsv
iavspecif
cell
enrich
within
lung
compar
blood
rsvspecif
cell
tracheal
aspir
children
remain
elev
convalesc
follow
sever
rsv
infect
contrast
murin
studi
studi
suggest
cell
respons
airway
may
prolong
follow
viral
clearanc
human
compar
mice
follow
respiratori
viru
infect
cell
becom
activ
develop
abil
produc
inflammatori
cytokin
virusspecif
cell
lung
airway
mice
upregul
express
marker
associ
activ
includ
well
downregul
express
lymphoid
home
receptor
activ
cell
also
acquir
effector
function
follow
viral
infect
virusspecif
cell
rapidli
produc
cytokin
includ
tnf
well
degranul
measur
express
follow
ex
vivo
peptid
stimul
human
virusspecif
cell
also
acquir
activ
phenotyp
effector
function
follow
respiratori
viru
infect
cell
tracheal
aspir
children
follow
rsv
rv
cov
infect
express
elev
level
activ
marker
hladr
prolifer
marker
express
effector
molecul
granzym
b
perforin
also
increas
similarli
cell
bronchiolar
lavag
bal
fluid
sampl
exhibit
increas
express
granzym
b
hladr
follow
either
experiment
rsv
infect
adult
sever
natur
rsv
infect
infant
addit
human
virusspecif
cell
produc
cytokin
follow
respiratori
viru
infect
peripher
blood
cell
secret
tnf
follow
stimul
peptid
deriv
rsv
iav
hmpv
rv
follow
contract
subset
virusspecif
cell
remain
host
form
longlast
memori
popul
provid
protect
subsequ
infect
cell
contract
form
longterm
memori
popul
lung
regul
part
inflammatori
chemokin
signal
mice
defici
either
exhibit
signific
increas
number
memori
cell
follow
iav
infect
suggest
chemokin
signal
play
critic
role
cell
memori
gener
follow
respiratori
viral
infect
mice
human
virusspecif
cell
detect
sever
month
postinfect
howev
respiratori
virusspecif
memori
cell
popul
declin
magnitud
age
peripher
blood
interestingli
adult
rsvspecif
cell
respons
significantli
reduc
compar
iavspecif
cell
respons
peripher
blood
suggest
memori
cell
respons
iav
human
may
stabl
rsv
memori
cell
rapidli
expand
lung
follow
secondari
respiratori
viru
infect
mice
human
observ
expans
primarili
due
migrat
circul
cell
lung
airway
rather
prolifer
resid
cell
expans
virusspecif
cell
lung
airway
follow
infect
correspond
increas
chemokin
support
role
chemokinemedi
migrat
cell
follow
secondari
infect
inde
express
memori
cell
requir
earli
recruit
airway
secondari
infect
lung
parenchyma
follow
secondari
expans
memori
cell
rapidli
produc
effector
cytokin
tnf
addit
virusspecif
memori
cell
express
high
level
produc
cytolyt
molecul
granzym
b
infect
effector
function
respiratori
virusspecif
memori
cell
critic
mediat
viral
clearanc
protect
infect
discuss
base
express
activ
marker
lymphoid
home
receptor
human
memori
cell
broadli
separ
four
major
subset
naiv
central
memori
tcm
effector
memori
tem
late
effector
memori
temra
due
express
tcm
home
primarili
secondari
lymphoid
organ
tem
migrat
peripher
tissu
rapidli
exert
effector
function
temra
subset
tem
cell
reexpress
exhibit
reduc
prolif
function
capac
thu
consid
termin
differenti
cell
human
virusspecif
memori
cell
popul
typic
compos
combin
tem
temra
within
peripher
blood
altern
rsvspecif
memori
cell
locat
airway
adult
infant
primarili
tem
phenotyp
also
express
high
level
low
level
togeth
studi
indic
tem
cell
domin
follow
respiratori
viru
infect
human
given
frequent
exposur
virus
respiratori
tract
tem
cell
may
critic
rapid
employ
cell
effector
mechan
follow
reinfect
recent
addit
popul
memori
cell
persist
within
peripher
tissu
identifi
term
tissueresid
memori
cell
trm
trm
observ
within
sever
peripher
organ
includ
intestin
skin
femal
reproduct
tract
lung
trm
gener
follow
respiratori
viru
infect
repres
noncircul
popul
memori
cell
maintain
within
lung
parenchyma
virusspecif
trm
locat
along
wall
larg
airway
within
pulmonari
tissu
surround
bronchiol
alveoli
respiratori
viru
infect
also
induc
trm
within
airway
lumen
airway
trm
downregul
express
distinguish
recent
traffick
cell
express
high
level
local
lung
airway
trm
follow
respiratori
viru
infect
distinctli
differ
tcm
traffic
pulmonari
vasculatur
accumul
lungdrain
lymph
node
virusspecif
tem
also
differenti
locat
trm
resid
primarili
pulmonari
vasculatur
within
lung
tissu
near
blood
vessel
spacial
distinct
region
contain
trm
follow
either
rsv
iav
infect
mice
lung
airway
trm
induc
identifi
express
canon
resid
memori
marker
promot
migrat
retent
within
lung
tissu
iav
rsvspecif
trm
also
gener
lung
mice
local
vaccin
via
intranas
rout
mice
immun
system
importantli
iavspecif
trm
express
also
detect
human
lung
tissu
section
absent
spleen
similarli
rsvspecif
trm
express
identifi
human
bal
present
peripher
blood
follow
secondari
viral
infect
trm
expand
prior
recruit
circul
memori
cell
popul
peripher
blood
rapidli
produc
thu
trm
provid
crucial
firstlin
defens
protect
host
reinfect
respiratori
viru
howev
contrast
memori
cell
subset
remain
stabl
long
period
time
iavspecif
trm
exhibit
limit
longev
enhanc
apoptosi
time
follow
infect
loss
iavspecif
trm
correspond
increas
viral
titer
weight
loss
follow
heterosubtyp
iav
infect
interestingli
infant
mice
gener
fewer
lung
trm
follow
iav
infect
vaccin
exhibit
reduc
heterosubtyp
protect
compar
mice
initi
infect
adult
given
role
lung
trm
provid
protect
respiratori
viru
infect
identifi
strategi
promot
gener
longliv
trm
critic
futur
vaccin
particularli
infant
popul
well
establish
cell
critic
viral
clearanc
follow
acut
respiratori
viru
infect
mice
adopt
transfer
cell
clone
result
significantli
reduc
viral
titer
lung
follow
rsv
iav
hmpv
infect
similarli
transfer
either
rsv
iavimmun
splenic
cell
acceler
viral
clearanc
lung
follow
infect
accordingli
rsv
infect
mice
deplet
cell
result
significantli
increas
lung
viral
titer
day
postinfect
although
viru
ultim
clear
day
contrast
deplet
cell
alon
alter
clearanc
hmpv
instead
deplet
cell
togeth
elev
lung
viru
titer
day
follow
infect
hmpv
importantli
cell
shown
suffici
mediat
viral
clearanc
lung
follow
acut
respiratori
infect
athym
nude
mice
lack
cell
fail
clear
either
rsv
iav
result
persist
infect
howev
transfer
either
rsv
iavimmun
splenic
cell
athym
mice
result
significantli
reduc
lung
viral
titer
day
respect
togeth
studi
indic
cell
play
critic
role
mediat
viral
clearanc
follow
acut
respiratori
infect
mice
although
studi
limit
role
cell
elimin
respiratori
virus
also
establish
human
earli
studi
demonstr
immunocompromis
children
cell
defect
experienc
prolong
viral
shed
follow
rsv
iav
piv
infect
compar
immunolog
normal
children
follow
bone
marrow
transplant
rsvinfect
child
sever
combin
immunodefici
mark
reduct
nasal
viral
load
observ
correl
elev
cell
count
recent
demonstr
number
preexist
virusspecif
cell
airway
adult
experiment
infect
rsv
correl
reduc
overal
viral
load
nasal
caviti
bronchial
brush
addit
preexist
cell
number
cell
effector
function
also
correl
reduc
viral
load
cell
target
cell
lysi
activ
measur
chromiumreleas
assay
correl
lack
viral
shed
nasal
wash
adult
experiment
infect
iav
addit
individu
lowest
frequenc
cell
exhibit
highest
viral
titer
follow
natur
iav
infect
studi
support
role
cell
respiratori
viru
clearanc
human
consist
numer
murin
studi
cell
mediat
viral
clearanc
util
varieti
effector
mechan
induc
apoptosi
virusinfect
cell
cell
use
direct
contact
elimin
target
cell
interact
surfac
molecul
fa
fasl
addit
trail
express
cell
interact
receptor
andor
induc
destruct
infect
cell
cell
also
secret
perforin
granzym
caus
membran
pore
format
induc
apoptosi
lastli
cell
produc
inflammatori
cytokin
tnf
may
either
directli
indirectli
promot
cell
death
virusinfect
cell
exact
mechan
util
unclear
mani
effector
function
associ
cellmedi
clearanc
respiratori
virus
fasfasl
interact
perforin
pathway
establish
primari
mechan
cell
elimin
infect
cell
follow
iav
infect
studi
util
traildefici
mice
antibodymedi
trail
blockad
also
demonstr
role
trail
cellmedi
clearanc
iav
similarli
fasfasl
perforin
pathway
also
associ
viru
elimin
follow
rsv
infect
perforindefici
fasldefici
gld
mice
exhibit
significantli
delay
viral
clearanc
howev
perforindefici
gld
mice
achiev
complet
viral
clearanc
day
postinfect
suggest
cell
compens
defici
altern
mechan
one
mechan
like
tnf
product
neutral
tnf
perforindefici
gld
mice
significantli
increas
viral
titer
compar
iggtreat
control
contrast
studi
follow
pvm
iav
infect
viral
clearanc
occur
independ
tnf
appear
play
promin
role
cellmedi
viral
clearanc
mice
mice
receiv
cell
exhibit
equival
viral
titer
wildtyp
mice
follow
rsv
pvm
iav
infect
togeth
studi
demonstr
cell
use
multipl
complementari
mechan
elimin
viral
infect
cell
follow
respiratori
viru
infect
given
abil
cell
mediat
viral
clearanc
follow
acut
viral
infect
surpris
memori
cell
also
play
critic
role
protect
secondari
respiratori
viru
infect
adopt
transfer
airway
iavspecif
memori
cell
result
significantli
reduc
lung
titer
follow
iav
challeng
compar
pb
transfer
control
similarli
transfer
airway
rsvspecif
memori
cell
reduc
lung
viral
load
weight
loss
follow
subsequ
rsv
infect
studi
indic
transfer
memori
cell
capabl
provid
protect
secondari
respiratori
viru
challeng
memori
cellmedi
protect
secondari
infect
shown
convincingli
mous
model
use
vaccin
strategi
gener
virusspecif
memori
cell
recombin
baculoviru
murin
cytomegaloviru
mcmv
vector
express
rsv
protein
induc
cell
mediat
reduct
lung
viral
titer
follow
rsv
challeng
whole
protein
vaccin
hmpv
viruslik
particl
contain
f
protein
elicit
hmpvspecif
cell
reduc
viral
titer
mice
lack
antibodi
cell
epitop
vaccin
either
rsv
hmpv
also
demonstr
cellmedi
protect
follow
challeng
reduc
lung
viral
load
histopatholog
compar
unimmun
control
similar
strategi
util
dcpeptid
vaccin
gener
preexist
pvmspecif
memori
cell
also
result
enhanc
viral
control
follow
pvm
infect
recent
sever
studi
util
dcprime
recombin
listeria
monocytogen
dclm
vaccinia
virusboost
dcvv
vaccin
protocol
gener
high
frequenc
preexist
antigenspecif
memori
cell
absenc
virusspecif
cell
memori
antibodi
primeboost
mice
exhibit
significantli
reduc
lung
viral
titer
follow
rsv
iav
sar
infect
compar
control
lack
virusspecif
memori
cell
addit
memori
cell
abl
reduc
weight
loss
mortal
follow
lethal
challeng
either
iav
sar
overal
studi
provid
clear
evid
memori
cell
provid
protect
secondari
respiratori
viru
infect
reduc
viral
titer
well
studi
exampl
memori
cellmedi
protect
secondari
respiratori
viru
infect
heterosubtyp
immun
iav
subtyp
iavspecif
neutral
antibodi
respons
recogn
surfac
glycoprotein
hemagglutinin
ha
neuraminidas
na
vari
subtyp
result
genet
reassort
known
antigen
drift
howev
intern
protein
viru
often
conserv
iav
subtyp
therefor
memori
cell
recogn
epitop
within
conserv
viral
protein
may
capabl
provid
crossprotect
iav
virus
differ
subtyp
evid
heterosubtyp
immun
first
demonstr
protect
iavimmun
mice
lethal
iav
challeng
without
induct
neutral
antibodi
respons
sinc
memori
cellmedi
role
acceler
clearanc
heterosubtyp
iav
strain
wellestablish
mous
chicken
nonhuman
primat
model
recent
demonstr
trm
essenti
provid
crossprotect
secondari
iav
infect
heterosubtyp
strain
mice
trm
lung
exhibit
effici
viral
clearanc
reduc
weight
loss
follow
heterosubtyp
challeng
mice
lack
trm
respons
importantli
protect
provid
sole
lungresid
memori
cell
block
abil
recent
prolifer
tcm
cell
traffick
lung
impact
protect
consist
limit
lifespan
iavspecif
trm
heterosubtyp
protect
memori
cell
wane
time
declin
observ
earli
day
follow
initi
infect
interestingli
system
immun
cognat
antigen
capabl
boost
trm
pool
expand
circul
tem
popul
seed
lung
therefor
possibl
trmmediat
heterosubtyp
protect
could
reestablish
vaccin
wane
protect
trm
popul
lung
protect
mous
model
well
establish
whether
memori
cell
play
critic
role
protect
follow
secondari
respiratori
infect
human
current
unclear
similar
studi
murin
model
evid
heterosubtyp
immun
mediat
memori
cell
also
demonstr
human
individu
lack
neutral
antibodi
titer
exhibit
invers
correl
memori
cell
activ
viral
shed
follow
first
exposur
iav
recent
demonstr
frequenc
preexist
crossreact
memori
cell
correl
reduc
symptom
includ
fewer
patient
fever
sore
throat
cough
follow
infect
pandem
iav
strain
similarli
correl
preexist
memori
cell
reduc
risk
viral
shed
follow
pandem
iav
infect
observ
thu
memori
cellmedi
heterosubtyp
protect
also
like
critic
human
follow
experiment
rsv
infect
human
frequenc
preexist
rsvspecif
memori
cell
airway
correl
reduct
cumul
lower
respiratori
tract
symptom
score
suggest
possibl
role
memori
cell
protect
rsv
human
howev
evid
also
provid
suggest
memori
cell
may
contribut
protect
follow
respiratori
viru
infect
human
natur
reinfect
infant
rsv
result
boost
cell
respons
similarli
frequenc
rsvspecif
memori
cell
peripher
blood
healthi
adult
significantli
reduc
compar
iavspecif
memori
cell
therefor
extent
memori
cell
play
role
provid
protect
rsv
infect
human
remain
unclear
despit
benefici
role
mediat
viral
clearanc
protect
secondari
infect
cell
also
associ
induct
immunopatholog
follow
respiratori
viru
infect
although
mice
deplet
cell
exhibit
elev
lung
viral
titer
weight
loss
symptom
ill
score
significantli
reduc
cell
deplet
mice
follow
acut
rsv
infect
similarli
adopt
transfer
cell
line
exacerb
weight
loss
follow
acut
rsv
infect
despit
acceler
viral
clearanc
similar
reduct
diseas
sever
also
demonstr
follow
either
hmpv
pvm
infect
cell
deplet
mice
mice
genet
defici
cell
respect
addit
induct
immunopatholog
follow
acut
respiratori
viru
infect
recent
demonstr
memori
cell
also
mediat
sever
immunopatholog
follow
secondari
rsv
infect
larg
frequenc
system
preexist
rsvspecif
memori
cell
gener
dclm
immun
induc
signific
weight
loss
pulmonari
dysfunct
mortal
follow
rsv
challeng
despit
signific
reduct
lung
viral
titer
result
contrast
studi
use
similar
immun
strategi
either
iav
sar
memori
cell
mediat
protect
lethal
viral
challeng
absenc
immunopatholog
interestingli
immunopatholog
induc
rsvspecif
memori
cell
occur
context
rsv
infect
mice
challeng
recombin
iav
strain
express
rsvderiv
cell
epitop
exhibit
significantli
reduc
morbid
protect
mortal
result
consist
sever
studi
demonstr
cell
enhanc
viral
clearanc
prevent
mortal
follow
iav
infect
togeth
studi
demonstr
clear
role
cell
develop
immunopatholog
follow
primari
secondari
infect
respiratori
viru
infect
particularli
rsv
antivir
mechan
util
cell
mediat
viral
clearanc
follow
respiratori
viru
infect
also
contribut
develop
immunopatholog
remov
fasfasl
pathway
gld
mice
result
signific
amelior
weight
loss
symptom
ill
score
follow
rsv
infect
similarli
rsvinfect
perforindefici
mice
exhibit
prolong
weight
loss
symptom
ill
score
compar
wildtyp
mice
tnf
contribut
substanti
immunopatholog
antibodymedi
deplet
tnf
prior
either
rsv
iav
infect
significantli
reduc
weight
loss
addit
mice
deplet
receiv
adopt
transfer
cell
prior
rsv
infect
lost
significantli
less
weight
control
cell
product
tnf
follow
pvm
infect
also
induc
pulmonari
immunopatholog
initi
cytokin
storm
addit
caus
diseas
acut
respiratori
infect
produc
memori
cell
mediat
sever
fatal
immunopatholog
follow
rsv
infect
dclm
primeboost
mice
role
cell
develop
patholog
follow
respiratori
infect
human
remain
unclear
best
evid
support
pathogen
role
cell
human
infect
respiratori
virus
come
studi
evalu
rsvinfect
severecombin
immunodefici
patient
bone
marrow
transplant
patient
exhibit
increas
cell
count
follow
bone
marrow
transplant
correspond
sharp
reduct
rsv
nasal
titer
howev
appear
cell
also
correl
mark
increas
respiratori
rate
indic
reduc
pulmonari
function
also
support
pathogen
role
cell
find
children
requir
mechan
ventil
due
sever
rsv
infect
express
significantli
increas
level
activ
granzym
cell
produc
granzym
b
compar
healthi
control
contrast
studi
infant
follow
either
fatal
iav
rsv
infect
reveal
near
absenc
cell
affect
lung
region
immunohistochem
stain
similarli
infant
sever
rsv
infect
exhibit
underexpress
gene
relat
cell
peripher
blood
support
protect
rather
pathogen
role
cell
correl
identifi
increas
cell
cytolyt
activ
cytokin
product
reduc
symptom
score
faster
recoveri
fewer
fatal
follow
iav
infect
therefor
whether
cell
play
primari
role
mediat
patholog
versu
protect
follow
human
respiratori
viru
infect
remain
controversi
import
topic
futur
investig
given
potenti
cell
effector
function
caus
immunopatholog
follow
respiratori
viru
infect
immun
system
evolv
critic
regulatori
mechan
prevent
prolong
cell
effector
activ
follow
viral
clearanc
cell
effector
function
includ
product
tnf
suppress
lung
follow
resolut
iav
rsv
infect
one
primari
mechan
util
limit
cell
respons
suppress
regulatori
cell
treg
treg
accumul
lung
follow
either
rsv
iav
infect
peak
approxim
day
postinfect
prior
peak
cell
respons
antibodymedi
deplet
treg
prior
rsv
infect
result
exacerb
weight
loss
pulmonari
dysfunct
lung
inflamm
enhanc
ill
correspond
increas
frequenc
rsvspecif
cell
elev
level
tnf
protein
lung
consist
treg
deplet
studi
increas
rsvspecif
treg
prior
rsv
infect
use
rsv
peptideimmun
result
amelior
weight
loss
reduct
cell
number
blood
spleen
lung
treg
also
suppress
cell
effector
function
follow
secondari
infect
iav
antibodymedi
treg
deplet
prior
heterosubtyp
iav
challeng
result
enhanc
inflamm
pulmonari
dysfunct
correspond
increas
cell
number
product
one
mechan
treg
may
suppress
cell
respons
product
antiinflammatori
cytokin
treg
secret
follow
primari
infect
rsv
iav
infect
either
mice
mice
treat
receptor
block
antibodi
result
increas
number
either
cell
suggest
suppress
cell
effector
function
follow
respiratori
viru
infect
interestingli
product
cell
cell
follow
either
rsv
iav
infect
also
report
indic
effector
cell
respons
may
selfregul
effector
function
togeth
studi
demonstr
treg
product
play
critic
role
regul
cell
follow
primari
secondari
respiratori
viru
infect
prevent
immunopatholog
interact
inhibitori
receptor
cell
ligand
repres
anoth
import
mechan
mediat
inhibit
cell
effector
function
follow
infect
regul
cell
pathway
common
inhibitori
pathway
util
follow
respiratori
viru
infect
express
pulmonari
cell
upregul
follow
rsv
iav
hmpv
infect
mice
blockad
primari
rsv
iav
hmpv
secondari
hmpv
infect
result
enhanc
cell
effector
function
includ
tnf
granzym
b
product
cell
effector
function
also
enhanc
follow
either
hmpv
iav
infect
mice
importantli
pathway
also
associ
human
cell
respons
human
cell
nasal
caviti
significantli
upregul
follow
rsv
infect
compar
cell
blood
either
healthi
rsvinfect
individu
also
upregul
lung
tissu
follow
sever
infect
either
rsv
iav
pandem
strain
vitro
human
studi
demonstr
constitut
express
human
airway
bronchial
epitheli
cell
express
significantli
upregul
follow
either
iav
rsv
infect
similar
vivo
mous
studi
vitro
blockad
result
significantli
increas
cell
product
granzym
b
follow
rsv
infect
togeth
studi
demonstr
critic
role
suppress
cellmedi
immunopatholog
cytokin
product
mice
human
absenc
signal
follow
hmpv
infect
cell
product
remain
impair
suggest
involv
compensatori
inhibitori
pathway
antigenspecif
lung
cell
express
inhibitori
receptor
follow
hmpv
infect
exhibit
enhanc
cytokin
product
follow
vitro
blockad
receptor
individu
vivo
blockad
partial
restor
cell
product
mice
follow
hmpv
infect
also
demonstr
critic
suppress
cell
respons
vivo
receptor
defici
mice
exhibit
significantli
enhanc
cell
respons
follow
primari
secondari
iav
infect
togeth
studi
indic
multipl
inhibitori
receptor
pathway
util
follow
pulmonari
viru
infect
dampen
pathogen
cell
respons
prevent
immunopatholog
success
vaccin
major
respiratori
virus
remain
elus
goal
vaccin
strategi
induc
robust
virusspecif
neutral
antibodi
respons
howev
antibodi
respons
gener
infect
mani
respiratori
infect
includ
rsv
rv
wane
time
therefor
neutral
antibodi
respons
sole
mediat
vaccin
respiratori
virus
may
provid
longterm
protect
without
yearli
vaccin
vaccin
strategi
includ
induct
virusspecif
cell
respons
either
alon
combin
humor
immun
may
advantag
provid
mani
benefit
associ
cellular
immun
respons
cell
critic
elimin
virusinfect
cell
viral
clearanc
prolong
absenc
cell
follow
acut
respiratori
viru
infect
addit
robust
memori
cell
respons
effici
reduc
lung
viral
titer
absenc
neutral
antibodi
follow
rsv
iav
sar
secondari
infect
import
properti
cell
often
recogn
conserv
viral
protein
allow
crossprotect
differ
viru
strain
particularli
import
heterosubtyp
protect
iav
strain
neutral
antibodi
capabl
recogn
iav
strain
differ
subtyp
despit
benefit
mediat
viral
clearanc
provid
protect
secondari
infect
memori
cell
respons
associ
induct
immunopatholog
follow
respiratori
viru
infect
antivir
mechan
employ
memori
cell
acceler
viral
clearanc
also
contribut
immunopatholog
includ
fasfasl
pathway
perforinmedi
cytolysi
tnf
cytokin
secret
thu
effici
elimin
respiratori
virus
memori
cell
come
cost
diseas
host
cellmedi
immunopatholog
appear
virusspecif
although
high
frequenc
system
antigenspecif
memori
cell
induc
sever
diseas
mortal
follow
rsv
infect
patholog
observ
use
similar
system
iav
sar
infect
therefor
induct
memori
cell
sole
immun
mediat
may
particularli
danger
rsv
vaccin
significantli
less
either
iav
sar
vaccin
abl
includ
cell
respons
within
futur
respiratori
viru
vaccin
extrem
import
determin
balanc
cellmedi
protect
versu
immunopatholog
follow
respiratori
infect
rsv
particular
three
critic
aspect
consid
balanc
includ
magnitud
local
regul
rsvspecif
cell
respons
figur
dclm
immun
gener
cell
frequenc
approxim
peripher
blood
induc
fatal
immunopatholog
follow
rsv
challeng
howev
dcprime
trivax
immun
gener
much
lower
frequenc
total
cell
rsv
induc
significantli
reduc
diseas
mice
thu
identifi
optim
magnitud
rsvspecif
cell
protect
absenc
immunopatholog
crucial
also
clear
recent
studi
mous
model
local
rsvspecif
cell
signific
factor
efficaci
mediat
viral
clearanc
abil
induc
immunopatholog
follow
infect
intranas
immun
mcmvm
gener
trm
within
lung
tissu
acceler
viral
clearanc
contrast
mice
administ
mcmvm
system
gener
trm
exhibit
delay
viral
clearanc
similar
result
observ
local
immun
lung
trm
gener
pulmonari
immun
induc
immunopatholog
follow
rsv
infect
contrast
system
dclm
immun
result
sever
patholog
absenc
trm
cell
thu
vaccin
strategi
rsv
like
effect
administ
pulmonari
rout
gener
trm
provid
protect
within
lung
follow
reinfect
without
induc
immunopatholog
lastli
identifi
way
regul
vaccinegener
cell
respons
like
reduc
immunopatholog
follow
subsequ
infect
produc
cell
primari
mediat
immunopatholog
follow
rsv
infect
dclm
vaccin
mice
howev
neutral
effect
lung
viral
titer
suggest
cell
util
antivir
mechan
mediat
viral
clearanc
system
sinc
cell
abl
reduc
viral
titer
absenc
reduc
amount
produc
cell
would
like
result
amelior
diseas
follow
rsv
infect
vaccin
strategi
identifi
mechan
cell
cytokin
product
particularli
attenu
without
alter
abil
elimin
virusinfect
cell
patholog
induc
cell
would
like
also
decreas
develop
cellmedi
vaccin
pursu
given
limit
antibodi
respons
respiratori
virus
possibl
ideal
vaccin
respiratori
viru
infect
includ
induct
virusspecif
cell
neutral
antibodi
vaccin
approach
combin
arm
adapt
immun
respons
may
allow
optim
viral
control
absenc
diseas
symptom
howev
cell
develop
mediat
protect
immun
balanc
protect
patholog
must
achiev
futur
studi
evalu
aspect
memori
cell
magnitud
local
regul
greatli
assist
reach
balanc
author
wrote
edit
manuscript
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
